Rousseau, A.-F., Ngongan, A., COLSON, C., MINGUET, P., NEIS GILSON, S., Cavalier, E., MINGUET, G., Misset, B., & Boemer, F. (16 August 2023). Mid-Term Evolution of the Serum Acylcarnitine Profile in Critically Ill Survivors: A Metabolic Insight into Survivorship. Nutrients, 15 (16), 3595. doi:10.3390/nu15163595 |
Rousseau, A.-F., Dongier, A., COLSON, C., MINGUET, P., Defraigne, J.-O., MINGUET, G., Misset, B., & Boemer, F. (19 May 2023). Serum Acylcarnitines Profile in Critically Ill Survivors According to Illness Severity and ICU Length of Stay: An Observational Study. Nutrients, 15 (10), 2392. doi:10.3390/nu15102392 |
Ngongan, A., Boemer, F., COLSON, C., Misset, B., MINGUET, G., & Rousseau, A.-F. (2023). Mid-term acylcarnitine profile evolution in survivors of a prolonged ICU stay. European Journal of Anaesthesiology, 40 (eSuppl 61), 280. |
Rousseau, A.-F., Dongier, A., COLSON, C., Misset, B., MINGUET, G., & Boemer, F. (2023). Acylcarnitine profile in survivors of a prolonged versus a short stay in ICU. European Journal of Anaesthesiology, 40 (e-Suppl 61), 279. |
Joris, M., Pincemail, J., COLSON, C., JORIS, J., CALMES, D., Cavalier, E., Misset, B., Guiot, J., MINGUET, G., & Rousseau, A.-F. (25 July 2022). Exercise Limitation after Critical Versus Mild COVID-19 Infection: A Metabolic Perspective. Journal of Clinical Medicine, 11 (15), 4322. doi:10.3390/jcm11154322 |
Rousseau, A.-F., Joris, M., Pincemail, J., COLSON, C., Cavalier, E., MINGUET, G., Joris, J., & Misset, B. (2022). Exercise intolerance in COVID‐19 ICU survivors compared to patients complaining of long COVID after mild disease: a metabolic perspective. Intensive Care Medicine Experimental, 10 (2), 166. |
JORIS, M., MINGUET, P., COLSON, C., JORIS, J., FADEUR, M., MINGUET, G., GUIOT, J., Misset, B., & ROUSSEAU, A.-F. (July 2021). Cardiopulmonary Exercise Testing in Critically Ill Coronavirus Disease 2019 Survivors: Evidence of a Sustained Exercise Intolerance and Hypermetabolism. Critical Care Explorations, 3 (7), 0491. doi:10.1097/CCE.0000000000000491 |
Nyssen, P., Mouithys-Mickalad, A., MINGUET, G., Sauvage, E., Wouters, J., Franck, T., & Hoebeke, M. (October 2018). Morphine, a potential inhibitor of myeloperoxidase activity. Biochimica et Biophysica Acta - General Subjects, 1862 (10), 2236-2244. doi:10.1016/j.bbagen.2018.07.007 |
Nyssen, P., Mouithys-Mickalad, A., MINGUET, G., & Hoebeke, M. (03 June 2018). Effect of pravastatin on the activation of equine neutrophils : An EPR spin trapping study [Poster presentation]. First Joint EPR school ARPE-GIRSE 2018. |
Nyssen, P., Mouithys-Mickalad, A., MINGUET, G., & Hoebeke, M. (05 December 2017). Study of the antioxidant action of two analgesic compounds, morphine and propofol, on the activity of MPO and HRP [Poster presentation]. Young Belgian Magnetic Resonance Scientist 2017, Blankenberge, Belgium. |
MINGUET, G., Franck, T., JORIS, J., & Serteyn, D. (2017). Sevoflurane modulates the release of reactive oxygen species, myeloperoxidase, and elastase in human whole blood: Effects of different stimuli on neutrophil response to volatile anesthetic in vitro. International Journal of Immunopathology and Pharmacology, 30 (4), 362-370. doi:10.1177/0394632017739530 |
Hoebeke, M., Nyssen, P., Franck, T., MINGUET, G., Serteyn, D., & Mouithys-Mickalad, A. (20 May 2016). Study of the antioxidant action of morphine on the peroxidase cycle of MPO and HRP [Poster presentation]. 24th Benelux EPR society meeting, Liège, Belgium. |
MINGUET, G., Franck, T., Mouithys-Mickalad, A., JORIS, J., Sandersen, C., & Serteyn, D. (17 September 2015). Morphine inhibits total and active myeloperoxidase degranulation from activated human polymorphonuclear neutrophils in a naloxone reversible manner and modulates the peroxidase and the chlorination activity of the enzyme [Paper presentation]. The 9th International Human Peroxidase Meeting, Cologne, Germany. |
Franck, T., MINGUET, G., Delporte, C., Derochette, S., Zouaoui Boudjeltia, K., Van Antwerpen, P., GACH, O., Deby-Dupont, G., Mouithys-Mickalad, A., & Serteyn, D. (2015). An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme. Free Radical Research, 1-10. doi:10.3109/10715762.2015.1027197 |
MINGUET, G., Franck, T., JORIS, J., Ceusters, J., Mouithys-Mickalad, A., Serteyn, D., & Sandersen, C. (2015). Effects of isoflurane and sevoflurane on the neutrophil myeloperoxidase system of horses. Veterinary Immunology and Immunopathology. doi:10.1016/j.vetimm.2015.02.010 |
MAVROPOULOS, G., MINGUET, G., & BRICHANT, J.-F. (2014). Alpha-2 adrenoreceptor agonists in anesthesia and intensive care medicine. Revue Médicale de Liège. |
Mavropoulos, G., MINGUET, G., & Brichant, J.-F. (2014). Interet des agonistes alpha-2 adrenergiques en anesthesie- reanimation. Revue Médicale de Liège, 69 (2), 97-101. |
MINGUET, G., Franck, T., Serteyn, D., & Sandersen, C. (2014). Effects of isoflurane and sevoflurane on horse neutrophil myeloperoxidase degranulation and activity [Poster presentation]. AVA meeting. |
Franck, T., MINGUET, G., Mossay, P., Zouaoui Boudjeltia, K., Mouithys-Mickalad, A., Derochette, S., & Serteyn, D. (12 September 2013). AN IMMUNOLOGICAL METHOD TO COMBINE THE MEASUREMENT OF ACTIVE AND TOTAL HUMAN MYELOPEROXIDASE ON THE SAME SAMPLE FROM A COMPLEX MEDIUM [Paper presentation]. 8th International Human Peroxidase Meeting, Sydney, Australia. |
MINGUET, G., de la Rebière de Pouyade, G., Franck, T., Joris, B., Serteyn, D., & Sandersen, C. (2013). Sevoflurane inhibits equine myeloperoxidase release and activity in vitro. Veterinary Anaesthesia and Analgesia, 40. doi:10.1111/j.1467-2995.2012.00786.x |
Ceusters, J., Serteyn, D., MINGUET, G., de la Rebière de Pouyade, G., Romainville, J., Dupont, G., Mouithys-Mickalad, A., & Franck, T. (15 December 2012). An in vitro whole blood model to test the effects of different stimuli conditions on the release of myeloperoxidase and elastase by equine neutrophils. Veterinary Immunology and Immunopathology, 150 (3-4), 221-7. doi:10.1016/j.vetimm.2012.09.008 |
MINGUET, G., Brichant, J.-F., & JORIS, J. (2012). Opioids and protection against ischemia-reperfusion injury: from experimental data to potential clinical applications. Acta Anaesthesiologica Belgica, 63 (1), 23-34. |
MINGUET, G., de la Rebière de Pouyade, G., Franck, T., JORIS, J., Sandersen, C., & Serteyn, D. (03 September 2010). Inhibition of equine myeloperoxidase activity by sevoflurane [Poster presentation]. AVA Autumn meeting, Santorini, Greece. |
Minguet, G., de la Rebière de Pouyade, G., Franck, T., Joris, J., & Serteyn, D. (2009). Inhibitory effect of sevoflurane on myeloperoxidase release by equine neutrophils [Paper presentation]. AVA Spring Meeting 2009, Helsinki, Finland. |
Minguet, G., Joris, J., & Lamy, M. (September 2007). Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics? [letter to the editor]. European Journal of Anaesthesiology, 24 (9), 733-745. doi:10.1017/S0265021507000531 |
Gaspar, A., MINGUET, G., DEWANDRE, P.-Y., & Hans, P. (2001). Evaluation of intubation conditions and safety following rapacuronium, succinylcholine or placebo during anesthesia with alfentanil and propofol. Acta Anaesthesiologica Belgica, 52, 215. |
GAspar, A., MINGUET, G., DEWANDRE, P.-Y., & HANS, P. (24 November 2000). Evaluation of intubating conditions and safety following rapacuronium, succinylcholine or placebo during anesthesia with alfentanil and propofol [Paper presentation]. SARB Residents Meeting, Brussels, Belgium. |
MINGUET, G., Gaspar, A., DEWANDRE, P.-Y., & HANS, P. (2000). Evaluation des conditions d’intubation et des effets secondaires après rapacuronium, succinylcholine ou placebo lors de l’induction de l’anesthésie avec l’alfentanil et le propofol [Paper presentation]. 42e congrès national de la SFAR, Paris, France. |